Abstract
At a time when the world faces an emotional breakdown, crushing our dreams, if not, taking our lives, we realize that together we must fight the war against the COVID-19 outbreak even if almost the majority of the scientific community finds itself confined at home. Every day, we, scientists, listen to the latest news with its promises and announcements. Across the world, a surge of clinical trials trying to cure or slow down the coronavirus pandemic has been launched to bring hope instead of fear and despair. One first proposed clinical trial has drawn worldwide hype to the benefit of chloroquine (CQ), in the treatment of patients infected by the recently emerged deadly coronavirus (SARS-CoV-2). We should consider this information in light of the long-standing anti-inflammatory and anti-viral properties of CQ-related drugs. Yet, none of the articles promoting the use of CQ in the current pandemic evoked a possible molecular or cellular mechanism of action that could account for any efficacy. Here, given the interaction of viruses with macroautophagy (hereafter referred to as autophagy), a CQ-sensitive anti-viral safeguard pathway, we would like to discuss the pros, but also the cons concerning the current therapeutic options ta...Continue Reading
References
Jul 3, 1993·BMJ : British Medical Journal·K Meeran, M G Jacobs
Feb 13, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J R BoelaertK Sperber
Aug 24, 2005·Virology Journal·Martin J VincentStuart T Nichol
Mar 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sandrine BelouzardGary R Whittaker
Feb 1, 2011·Nature Genetics·Patrick BrestPaul Hofman
Aug 11, 2011·MBio·André Moraes NicolaArturo Casadevall
Jun 14, 2013·Journal of Virology·Alexsia L Richards, William T Jackson
Aug 27, 2013·Immunity·Yuting MaGuido Kroemer
Dec 30, 2014·Methods : a Companion to Methods in Enzymology·Junya HasegawaTamotsu Yoshimori
Feb 6, 2017·Nature·Jonathan Kimmelman, Carole Federico
Jan 28, 2020·Lancet·Chaolin HuangBin Cao
Feb 3, 2020·Lancet·Roujian LuWenjie Tan
Feb 20, 2020·Bioscience Trends·Jianjun GaoXu Yang
Feb 23, 2020·The Lancet Infectious Diseases·Ensheng DongLauren Gardner
Mar 8, 2020·International Journal of Antimicrobial Agents·Philippe ColsonDidier Raoult
Mar 10, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Xueting YaoDongyang Liu
Mar 21, 2020·Cell Discovery·Jia LiuManli Wang
Mar 25, 2020·International Journal of Antimicrobial Agents·Philippe GautretDidier Raoult
Mar 26, 2020·JAMA : the Journal of the American Medical Association·Andre C Kalil
Apr 25, 2020·JAMA Network Open·Mayla Gabriela Silva BorbaUNKNOWN CloroCovid-19 Team
Apr 28, 2020·JAMA Network Open·Mayla Gabriela Silva BorbaUNKNOWN CloroCovid-19 Team
May 16, 2020·BMJ : British Medical Journal·Matthieu MahévasNathalie Costedoat-Chalumeau
Mar 19, 2021·Cell Discovery·Jia LiuManli Wang
Citations
Dec 1, 2020·Autophagy·Marie-Angela DomdomBaharia Mograbi
Nov 7, 2020·Autophagy·Elizabeth Delorme-Axford, Daniel J Klionsky
Apr 6, 2021·Cell Biology International·Saman SargaziNima Rezaei
May 1, 2021·International Journal of Molecular Sciences·Gustavo José da Silva PereiraClaudia Bincoletto
May 6, 2021·Cell Discovery·Yabin ZhangKefeng Lu
Aug 14, 2021·Frontiers in Cell and Developmental Biology·Yafei QuQiming Liang
Aug 28, 2021·Cells·Ankit Shroff, Taras Y Nazarko
Sep 23, 2021·Journal of Virology·Chao ShangXiao Li